Andere Sprachen Zydus Lifesciences Limited

Aktien

A141X0

INE010B01027

ZYDUSLIFE

Pharmazeutika

Markt geschlossen - NSE India S.E. Andere Börsenplätze 13:16:09 12.01.2026			% 5 Tage	Veränd. 1. Jan.
895,05 ^INR	+0,02 %		-2,92 %	-2,11 %

09.01.	FDA genehmigt erste generische Robenacoxib-Tablette zur Behandlung von postoperativen Schmerzen bei Katzen	RE
02.01.	Zydus Lifesciences' luxemburgische Tochtergesellschaft Auroralux wird aufgelöst	MT

Andere Sprachen

09.01.	FDA approves first generic robenacoxib tablet for postoperative pain in cats
07.01.	The 'Wow' Factor: Section 11 And the Jurisprudence of Trademark Confusion in Food Brands
02.01.	Zydus Lifesciences' Luxembourg-Based Subsidiary Auroralux Gets Dissolved
30.12.	Zydus Lifesciences gets tax demand order of 28 million rupees
24.12.	Zydus Lifesciences and Sterling Biotech extend API business acquisition closing to June 30
24.12.	Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO(R), an Interchangeable Biosimilar to Lucentis(R)
24.12.	Lilly, Novo lock horns in India's obesity drug race
23.12.	Formycon Obtains US FDA Approval for Interchangeable Lucentis Biosimilar
23.12.	Zydus Partners with Bioeq for U.S. Commercialisation rights for NUFYMCO®, an Interchangeable Biosimilar to Lucentis®
23.12.	Zydus Lifesciences partners with bioeq for U.S. rights to NUFYMCO
19.12.	Indian Equities Rebound on Friday as Rupee Stability Lifts Sentiment
19.12.	Zydus Lifesciences Signs Pact to Launch Cancer-Risk Assessment Diagnostic Tests in India
19.12.	Zydus Lifesciences signs agreement with Myriad Genetics for cancer-risk tests in India
19.12.	Zydus Lifesciences Limited Signs an Exclusive Agreement with Myriad Genetics
15.12.	Zydus Lifesciences says FDA accepts Sentynl's CUTX-101 NDA resubmission
10.12.	Indian Equities Extend Losses as Investors Turn Cautious Ahead of US Rate Decision
10.12.	Zydus Lifesciences Launches Denosumab Biosimilar
10.12.	Zydus Lifesciences launches biosimilar denosumab 120 mg SC
10.12.	Zydus Lifesciences Limited Launches Biosimilar Denosumab 120 Mg Sc - Protecting Bone Health in Cancer Patients
09.12.	Formycon, Zydus Sign Exclusive Deal for Keytruda Biosimilar in US, Canada
09.12.	Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206
04.12.	Zydus Lifesciences Gets US FDA's Establishment Inspection Report for Jarod, India Unit
04.12.	Zydus Lifesciences receives EIR for injectable facility located at Jarod
27.11.	Zydus Lifesciences receives tentative approval from USFDA for empagliflozin and linagliptin tablets
27.11.	Zydus Lifesciences Limited Receives Tentative Approval from USFDA for Empagliflozin and Linagliptin Tablets, 10 mg/5 mg and 25 mg/5 mg

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen MarketScreener Artikel MarketScreener Analysen Trading-Ideen

Andere Sprachen Zydus Lifesciences Limited

Aktien

A141X0

INE010B01027

ZYDUSLIFE

Pharmazeutika

Andere Sprachen

Filter